Novaerus

About:

Novaerus Improve the business and quality of care through the application of airborne pathogen control technology.

Website: http://www.novaerus.com/

Twitter/X: Novaerus

Top Investors: F-Prime Capital, Polaris Partners, Eight Roads Ventures, Summit Bridge Capital

Description:

Novaerus's mission is to improve the business and quality of care through the application of airborne pathogen control technology. Novaerus believe that the preventative approach is the proper path to improved business and quality results in skilled nursing and assisted living facilities. Traditionally, important steps have been taken to clean hands and surfaces. Protocols exist on hand washing, surface cleaning and disinfectant and even isolation used as a tactic to prevent pathogens. When used in conjunction with these traditional methods, the Novaerus technology can go beyond just scrubbing hands and surfaces.

Total Funding Amount:

$10M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)novaerus.com

Founders:

Graham Deane, Kevin Maughan

Number of Employees:

11-50

Last Funding Date:

2015-12-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai